Immatics (IMTX) Gains from Investment Securities (2020 - 2025)
Immatics' (IMTX) quarterly Gains from Investment Securities came in at -$1.2 million in Q4 2025, up 88.93% year-on-year from -$650624.8 in Q4 2024, and up 60.5% quarter-over-quarter from -$3.1 million in Q3 2025.
Immatics (IMTX) Gains from Investment Securities (2020 - 2025) Analysis & Trends
Immatics has disclosed Gains from Investment Securities across 5 years of filings, most recently posting -$1.2 million for Q4 2025.
- Gains from Investment Securities for Q4 2025 came in at -$1.2 million, up 88.93% year-over-year; the trailing twelve-month figure through Dec 2025 was -$10.1 million (up 27.95% YoY), and the FY2025 annual result was -$10.4 million, up 26.04% from the prior year.
- Gains from Investment Securities came in at -$1.2 million for Q4 2025 at Immatics, up from -$3.1 million in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $23.3 million in Q4 2021 to a low of -$11.1 million in Q4 2024.
- The 4-year median for Gains from Investment Securities is -$1.4 million (2025), against an average of $524251.1.
- Across the five-year window, Gains from Investment Securities jumped 1165.71% in 2022 and sank 742.74% in 2025, its largest moves.
- Immatics' Gains from Investment Securities stood at $23.3 million in 2021, then slumped by 66.51% to $7.8 million in 2022, then tumbled by 242.22% to -$11.1 million in 2024, then jumped by 88.93% to -$1.2 million in 2025.
- The last three Gains from Investment Securities figures came in at -$1.2 million (Q4 2025), -$3.1 million (Q3 2025), and -$646349.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Immatics | 14.67 Bn | 14.67 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.23 Mn |
| Dec 31, 2025 | -1.23 Mn |
| Sep 30, 2025 | -3.11 Mn |
| Sep 30, 2025 | -3.11 Mn |
| Jun 30, 2025 | -646,348.98 |
| Jun 30, 2025 | -646,348.98 |
| Mar 31, 2025 | -5.13 Mn |
| Mar 31, 2025 | -5.13 Mn |
| Dec 31, 2024 | -11.10 Mn |
| Dec 31, 2024 | -11.10 Mn |
| Sep 30, 2024 | -762,164.33 |
| Sep 30, 2024 | -762,164.33 |
| Jun 30, 2024 | -1.56 Mn |
| Jun 30, 2024 | -1.56 Mn |
| Mar 31, 2024 | -608,362.59 |
| Mar 31, 2024 | -608,362.59 |
| Dec 31, 2022 | 7.81 Mn |
| Dec 31, 2022 | 7.81 Mn |
| Sep 30, 2022 | -5.91 Mn |
| Sep 30, 2022 | -5.91 Mn |